North America Medical Device Contract Manufacturing Market Size, Share & Growth Trend Analysis Report (2026 - 2035)

Market Outlook

The North America medical device contract manufacturing market, valued at USD 40.9 billion in 2025, is projected to reach USD 43.9 billion in 2026 and USD 75.5 billion by 2035, with a CAGR of 6.2% during the forecast period 2026 to 2035.

To learn more about this report, request a free sample copy

Market Report: Key Takeaways

Market Size and Trends

• By class of medical device, the class III medical devices are likely to hold the highest (around 50%) share of the market in 2026; this trend is unlikely to change in the future.
• With respect to type of medical device, the therapeutic devices subsegment dominates (approximately 45%) the current market.
• Based on therapeutic area, in 2026, cardiovascular disorders capture the largest North America medical device contract manufacturing market value.
• In terms of company size, mid-sized companies are likely to hold the highest share of the market in 2026; this trend is unlikely to change in the future.

Key Market Statistics

• Market Size in 2026: $43.9 billion
• Estimated Market Size in 2035: $75.5 billion
• CAGR (Till 2035): 6.2%

Market Introduction

Medical device contract manufacturing has emerged as a critical enabler of innovation and large-scale commercialization within the global medtech industry. As medical devices become increasingly sophisticated through the integration of advanced electronics, sensors, software and sterile packaging technologies, OEMs are increasingly outsourcing design transfer, prototyping, precision manufacturing, assembly, validation, and commercial production to specialized CMOs. This strategic approach enables OEMs to optimize capital investments, accelerate product development timelines, and focus on core competencies such as research, innovation, and market expansion.

North America represents the largest and most advanced market for medical device contract manufacturing, driven by its robust medtech ecosystem and strong culture of innovation. The US, in particular, continues to generate significant demand for contract manufacturing services through sustained product development across diagnostics, surgical systems, patient monitoring, and digital health technologies. Reinforcing this momentum, the FDA's Center for Devices and Radiological Health (CDRH) authorized 124 novel medical devices in 2025. This highlights the region's strong innovation pipeline and the increasing need for manufacturing partners with expertise in regulatory compliance, quality management systems, and cleanroom manufacturing.

The region is further supported by a well-established network of contract manufacturers specializing in complex medical device categories, including minimally invasive devices, robotic-assisted surgical systems, in vitro diagnostics, cardiovascular products, diabetes care solutions, and drug delivery technologies. Industry leaders such as Jabil, Flex, and Viant offer comprehensive capabilities spanning engineering, manufacturing, supply chain management, assembly, validation, and commercialization, enabling OEMs to efficiently transition products from concept to large-scale production.

Canada and Mexico further enhance North America's manufacturing competitiveness. Canada offers a mature healthcare ecosystem supported by an aging population, strong adoption of advanced medical technologies, and continued investments in healthcare innovation. Meanwhile, Mexico has emerged as a leading nearshoring destination and export hub for US-bound medical devices, leveraging its cost-efficient manufacturing capabilities, skilled workforce, and well-integrated supply chain network. Collectively, these advantages reinforce North America's position as a strategic hub for medical device contract manufacturing, supported by a high concentration of innovation, regulatory maturity, and resilient regional supply chains.

Leading US - based Companies in Medical Device Contract Manufacturing Market

Market Segmentation

Based on the research, we have segmented the North America medical device contract manufacturing market report into class of medical device, type of medical device, therapeutic area, company size, and leading players.

By Class of Medical Device

• Class I
• Class II
• Class III

By Type of Medical Device

• Therapeutic Devices
• Diagnostic Devices
• Drug Delivery Devices
• Other Medical Devices

By Therapeutic Area

• Cardiovascular Disorders
• Orthopedic Disorders
• Metabolic Disorders
• Neurological Disorders
• Ophthalmological Disorders
• Respiratory Disorders
• Oncological Disorders
• Gastrological Disorders
• Other Disorders

By Company Size

• Very Small
• Small
• Mid-sized
• Large

Key Market Insights

What Factors are Driving Increased Adoption of Medical Device Contract Manufacturing in North America?

• Rising Innovation in Advanced Medical Devices: The rapid adoption of minimally invasive surgical devices, robotic-assisted surgical systems, wearable medical devices, in vitro diagnostics (IVDs), cardiovascular implants, diabetes care devices, and digital health technologies is driving demand for highly specialized manufacturing capabilities. These sophisticated products require precision engineering, cleanroom manufacturing, advanced automation, and stringent quality management systems, encouraging OEMs to collaborate with experienced contract manufacturers possessing technical and regulatory expertise.
• Expansion of Regional Manufacturing and Nearshoring Initiatives: Growing emphasis on supply chain resilience and domestic manufacturing is encouraging OEMs to strengthen their North American production footprint. The US government has promoted domestic manufacturing of critical healthcare products, while Mexico has emerged as a preferred nearshoring destination due to its cost-effective manufacturing capabilities, skilled workforce, and proximity to the US market. Moreover, Puerto Rico-based Viant expanded its facility from injection molding into subassembly, finished-device assembly, and combination drug-delivery-device manufacturing. These trends are increasing investments in regional contract manufacturing facilities and expanding production capacity across North America.

What are the Main Challenges in North America Medical Device Contract Manufacturing Market Growth?

• Stringent Regulatory and Quality-Compliance Requirements: Contract manufacturers must comply with extensive documentation, supplier-control, validation, risk-management and inspection requirements. The FDA's Quality Management System Regulation, effective February 2, 2026, aligns US requirements more closely with ISO 13485:2016 and permits greater inspection of quality, supplier-audit and management-review records.
• Supply Chain Disruptions and Raw Material Availability: The market remains vulnerable to shortages of electronic components, semiconductors, medical-grade polymers, specialty metals, and other critical raw materials. Global geopolitical uncertainties, transportation bottlenecks, and supplier concentration can delay production schedules, increase procurement costs, and affect the timely delivery of finished medical devices.

Recent Developments in North America Medical Device Contract Manufacturing Market

• In May 2026, Tecomet and Orchid Orthopedic Solutions completed their merger, forming a scaled global manufacturing partner for MedTech OEMs. The combined company expands capabilities across precision machining, additive manufacturing, forging, casting and advanced finishing.
• In March 2026, Resonetics completed its acquisition of Resolution Medical, expanding integrated design, finished device and sub-assembly capabilities for interventional, structural heart and neuromodulation programs. The transaction adds cleanroom assembly, NPI and commercialization support for complex regulated devices.
• In January 2026, AbbVie, a US-based company, entered an agreement to acquire the manufacturing facility of West Pharmaceutical Services, to further strengthen its drug delivery device manufacturing capabilities and broaden access to the growing MedTech industry.

Industry Experts on North America Medical Device Contract Manufacturing Market

The market for medical device contract manufacturing in North America has a transformative future and is likely to remain progressive in the future. A key driver of progression is the rising potential of medical devices, particularly combination products, to treat chronic diseases.

Sara E. Dyson (Vice President of Underwriting Operations and Risk Management, Medmarc Insurance), stated that, "The most significant change in outsourcing over the last 20 years has been the evolution of CMOs offering solely manufacturing services to offering manufacturing services in addition to an array of services related to product design, project management, quality and regulatory, and aftermarket logistics"

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes transcripts of the following discussions:

• Chief Research and Technology Director, Mid-sized Company, US
• Former President and Chief Executive Officer, Large Company, Sweden

In addition, the market report includes transcripts of the following third-party discussions:

• Chief Executive Officer, Mid-sized Company, Hungary
• Chief Operating Officer, Large Company, US
• Senior Vice President of Head of Commercial, Large Company, US
• Vice President Global Marketing and Commercial Operations, Large Company, US
• Senior Director Business Development Medical Device, Very Large Company, China
• Director of Business Development, Small Company, Sweden
• Senior Account Manager, Mid-sized Company, Canada
• Technical Director and Partner, Small Company, India
• Assistant Manager, Small Company, India
• General Manager, Small Company, Germany
• Former Lead Trainer and QC Manager, Mid-sized Company, Pakistan
• Former Business Development Consultant, Mid-sized Company, Germany
• Former Research Study Assistant, Small Company, Germany

Market Share Insights

Which Class of Medical Device Accounts for the Largest Market Share?

• Based on the North America medical device contract manufacturing market analysis, Class III devices are likely to occupy the highest (around 50%) market share in 2026. Further, this segment is likely to witness a significant growth rate during the forecast period.
• This is due to the stringent development and manufacturing requirements associated with Class III medical devices, owing to their high-risk nature and rigorous regulatory standards. Consequently, medical device companies increasingly outsource critical manufacturing activities to specialized contract manufacturing organizations that possess technical expertise, advanced infrastructure, and regulatory capabilities required to ensure product quality, compliance, and timely commercialization.

Which Type of Medical Device Accounts for the Largest North America Medical Device Contract Manufacturing Market Share?

• In 2026, the therapeutic devices segment is likely to occupy the highest (~45%) market share. Further, this segment is likely to witness a significant growth rate during the forecast period. This is because of the increasing demand for high-value, technologically advanced therapeutic devices, including cardiovascular implants, orthopedic implants, diabetes management devices, neuromodulation systems, and robotic-assisted surgical equipment.
• The drug delivery devices segment is likely to witness a higher CAGR in the future; this is due to the rising prevalence of chronic diseases, growing adoption of self-administered and wearable drug delivery systems, and increasing demand for biologics and combination products requiring specialized delivery mechanisms.

Amongst the Company Sizes, Which Segment Holds the Highest Share in the North America Medical Device Contract Manufacturing Market?

• Currently, the mid-sized companies occupy a higher North America medical device contract manufacturing market share. This is primarily due to their ability to offer specialized manufacturing solutions tailored to specific medical device categories and therapeutic applications. Moreover, these companies typically provide greater operational flexibility, shorter project turnaround times, and more cost-effective and transparent pricing models, making them preferred partners for start-ups and small-to-mid-sized medical device OEMs seeking high-quality manufacturing services without significant capital investment.
• The large companies are likely to grow at a higher CAGR (7.8%) during the forecast period. This is primarily because of their ability to deliver integrated, end-to-end manufacturing services at commercial scale, coupled with significant investments in automation, digital manufacturing, and global supply chain networks.

Scope of North America Medical Device Contract Manufacturing Market Report